|
|
Line 18: |
Line 18: |
|
| |
|
| =Text= | | =Text= |
| {{#Wiki_filter:/RA/}} | | {{#Wiki_filter:October 2, 2018 Mr. B. Joel Burch, Vice President and General Manager BWXT Nuclear Operations Group, Inc. |
| | P.O. Box 785 Lynchburg, VA 24505-0785 |
| | |
| | ==SUBJECT:== |
| | LETTER OF APPRECIATION FOR THE TOUR OF THE RESEARCH TEST REACTOR FUEL FABRICATION FACILITY PROVIDED TO THE U.S. NUCLEAR REGULATORY COMMISSION ON AUGUST 21, 2018 (EPID NO. L-2017-PMP-0014) |
| | |
| | ==Dear Mr. Burch:== |
| | |
| | On August 21, 2018, 13 members of the U.S. Nuclear Regulatory Commission (NRC) Division of Licensing Projects, Research and Test Reactors Oversight Branch, and Research and Test Reactors Licensing Branch staff, participated in a tour of the BWXT Research Test Reactor Fuel Fabrication Facility in Lynchburg, Virginia. The purpose of the tour was to gain insights into both the existing research reactor plate fuel production process, as well as the fuel development work being conducted in conjunction with the U.S. Department of Energy, Office of Material Management and Minimization, High Performance Research Reactor Conversion project. |
| | The NRC staff gained important technical insights on this tour, and will be better informed with respect to future licensing actions involving research reactor fuel. Furthermore, the NRC staff recognized the level of effort expended by BWXT to provide this tour, and wish to express its appreciation to your staff: Mr. Van Mauney, Mr. David Miller, Mr. Scott Niedzialek, Mr. Chris Terry, Mr. Stephen Subosits, and Ms. Sandra Rice, and other BWXT staff, who provided both technical tour information as well as coordinated itinerary, schedule, and site access support. |
| | If you have any questions, please contact Mr. Geoffrey Wertz at 301-415-0893, or by electronic mail to Geoffrey.Wertz@nrc.gov. |
| | Sincerely, |
| | /RA/ |
| | Mary Jane Ross-Lee, Deputy Division Director Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 70-27 License No. SNM-42 |
| | |
| | ML18268A344 *concurrence via email OFFICE NRR/DLP/PRLB/PM* NRR/DLP/PRLB/LA* NRR/DLP/PRLB/BC NRR/DLP/DD NAME GWertz NParker AAdams MJRoss-Lee DATE 9/26/2018 9/26/2018 10/1/2018 10/2/2018}} |
Latest revision as of 14:12, 20 October 2019
Letter Sequence Other |
---|
|
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance...
Results
Other: ML18054A077, ML18087A340, ML18127B706, ML18128A034, ML18155A603, ML18162A117, ML18162A118, ML18162A129, ML18193A141, ML18268A344, ML18340A171, ML18340A276, ML19015A352, ML19071A185
|
MONTHYEARML18030A7422017-07-14014 July 2017 Irrevocable Standby Letter of Credit (Redacted) Project stage: Request ML18054A0772018-03-0808 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18092A0872018-03-27027 March 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18087A3892018-03-28028 March 2018 Meeting Slides for the April 3, 2018, Public Meeting Between Shine Medical Technologies. Inc. and the NRC Project stage: Request ML18162A0542018-03-28028 March 2018, 29 March 2018, 3 April 2018, 18 June 2018 Shine Medical Technologies, Inc. April 3, 2018 Public Meeting Project stage: Request ML18096A6882018-04-0303 April 2018 Confirmatory Action Letter (CAL) No. NRR-2011-001 Project stage: Request ML18096A4552018-04-0303 April 2018 Shine Operating License Pre-Application Meeting (Environmental Presentation Slides) Project stage: Request ML18087A3402018-04-0303 April 2018 Response to Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18096A6892018-04-0303 April 2018 Arrr Restart Plan (4/3/2018) Approach to Critical, Control Rod and Power Calibrations Project stage: Request ML18130A5782018-05-0707 May 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18162A1362018-05-11011 May 2018, 18 June 2018 Shine Medical Technologies, Inc. May 23, 2018 Public Meeting Project stage: Request ML18138A2912018-05-16016 May 2018 Shine Medical Technologies, Inc. - Submittal of Meeting Slides for the May 23 and 24, 2018 with NRC Project stage: Request ML18128A0342018-05-16016 May 2018 Response to Second Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18156A1302018-06-0101 June 2018 Inc. - Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18155A6032018-06-0707 June 2018 Response to Third Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18162A1172018-06-18018 June 2018 Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report Project stage: Other ML18162A0552018-06-18018 June 2018 Shine Medical Technologies April 3, 2018 Public Meeting Summary Project stage: Meeting ML18162A1162018-06-18018 June 2018 Shine Medical Technologies Annual Financial Report Project stage: Request ML18162A1182018-06-18018 June 2018 Shine Medical Technologies Response to Request for Withholding Letter for 2016 Annual Financial Report Project stage: Other ML18162A1292018-06-18018 June 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions Project stage: Other ML18162A1382018-06-18018 June 2018 May 23-24, 2018, Summary of Meeting with Shine Medical Technologies, Inc Project stage: Meeting ML18127B7062018-06-21021 June 2018 Closure of NRC Confirmatory Action Letter No. NRR-2011-001 Project stage: Other ML18221A4532018-06-27027 June 2018, 17 August 2018 Shine Medical Technologies, Inc. June 2018 Public Meeting Project stage: Request ML18187A2162018-07-0202 July 2018 Resubmittal of Meeting Slides for the June 28, 2018, Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML18197A0802018-07-10010 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Request ML18193A1412018-07-16016 July 2018 Response to Fourth Request for Extension of Time to Respond to Letter Regarding Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML18277A1962018-07-17017 July 2018 Amendment to Standby Letter of Credit (Redacted) Project stage: Request ML18206A7262018-07-18018 July 2018 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor (Redacted) Project stage: Request ML18221A4542018-08-17017 August 2018 Summary of Meeting with Shine Medical Technologies, Inc. Project stage: Meeting ML18239A2192018-08-27027 August 2018 Request for Confirmation of the 10 CFR Part 140 Financial Protection Requirements for the Shine Facility Project stage: Request ML18268A3442018-10-0202 October 2018 Letter of Appreciation for the Tour of the Research Test Reactor Fuel Fabrication Facility Provided to the U.S. Nuclear Regulatory Commission on August 21, 2018 EPID No. L-2017-PMP-0014 Project stage: Other ML18340A1712018-12-10010 December 2018 Shine Medical Technologies, Inc. - Acknowledgement of Receipt of Periodic Report on Construction Permit Conditions Project stage: Other ML18340A2762018-12-19019 December 2018 Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Request for Confirmation of Applicable Financial Protection Requirements Project stage: Other ML19025A2642019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19024A3522019-01-22022 January 2019 Shine Medical Technologies - Meeting Slides for the January 31, 2019 Public Meeting Between Shine Medical Technologies, Inc. and the NRC Project stage: Request ML19025A2752019-01-22022 January 2019 Shine Medical Technologies, Inc. Submittal of Meeting Slides for the January 29 and 30, 2019 Meeting with the NRC Project stage: Request ML19015A3522019-02-15015 February 2019 Irrevocable Standby Letter of Credit for the Aerotest Radiography and Research Reactor Project stage: Other ML19071A1852019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding from Public Disclosure Project stage: Other ML19071A1812019-03-22022 March 2019 Shine Medical Technologies, Inc. - January 31, 2019 Public Meeting Summary Project stage: Meeting ML19071A1792019-03-22022 March 2019 Shine Medical Technologies, Inc. January 31, 2019 Public Meeting Project stage: Request ML19071A1802019-03-22022 March 2019 Shine Medical Technologies, Inc. - Request for Withholding Information from Public Disclosure Project stage: Withholding Request Acceptance 2018-06-18
[Table View] |
|
---|
Category:Letter
MONTHYEARML24281A1382024-10-0707 October 2024 BWXT Mca IR 2024405 Public Cover Letter ML24233A2702024-09-10010 September 2024 Cover Letter: Return of Argonaut Insurance Company Surety Bond ML24236A7672024-08-26026 August 2024 BWXT Nuclear Operations Group - Lynchburg - Physical Security Core Inspection Report 07000027-2024403 ML24234A0592024-08-16016 August 2024 BWXT Nuclear Operations Group, Inc., Semi-Annual Effluent Monitoring Report ML24205A0802024-07-24024 July 2024 BWXT Nuclear Operations Group, Inc. – Integrated Inspection Report 07000027/2024002 ML24179A1982024-06-27027 June 2024 BWXT Nuclear Operations Group, Inc. - Lynchburg Inspection Schedule for Calendar Year 2025 ML24151A4602024-06-20020 June 2024 BWXT Nuclear Operations Group, Inc. – NRC Core Inspection Report 07000027/2024006 and Apparent Violation ML24135A0762024-05-0101 May 2024 BWXT Nuclear Operations Group, Inc. - Lynchburg - Decommissioning Surety Bond ML24116A2842024-04-26026 April 2024 BWXT Nuclear Operations Group, Inc. - Integrated Inspection Report 07000027-2024001 ML24060A2822024-04-18018 April 2024 Cover Letter BWXT Amendment 47 (Public) ML24089A1862024-03-29029 March 2024 BWXT Nuclear Generating Group, Inc. - Material Control and Accounting Program Inspection Report 07000027/2024404 - Public ML24064A2142024-03-0404 March 2024 BWXT Nuclear Operations Group- Lynchburg - Physical Security Core Inspection Report 07000027/2024402 - Public Cover Letter ML24065A0142024-02-29029 February 2024 Response to Request for Additional Information Regarding Submittal for Exemption from Implementation of Security Event Notification and Suspicious Activity Reporting ML24064A0352024-02-27027 February 2024 BWXT Nuclear Operations Group- Lynchburg, Inc., Submittal of Fitness for Duty Program Annual Data Report for 2023 ML24061A0222024-02-27027 February 2024 BWXT Nuclear Operations Group, Inc., Lynchburg - Semi-Annual Effluent Monitoring Report ML24036A2482024-02-0808 February 2024 Request for Additional Information from BWXT NOG-L Regarding Submittal for Security Exemption-Enterprise Project Identifier L-2023-SPR-0013 ML24024A1502024-01-25025 January 2024 BWXT Nuclear Operations Group, Inc. – Integrated Inspection Report 07000027/2023004 ML24019A1492024-01-24024 January 2024 BWXT Nuclear Operations Group, Inc. -Lynchburg, U.S. NRC Inspection Report 0700027/2022006 and Notice of Violation ML24016A1912024-01-17017 January 2024 TRISO-X - U.S. Nuclear Regulatory Commission Inspection Report 07007027/2023006 ML23325A0382023-11-16016 November 2023 BWXT Nuclear Operations Group, Inc. - Lynchburg, Request for Exemption from Security Event Notification and Suspicious Activity Reporting Implementation in Accordance with 10 CFR 73.5 ML23325A0402023-11-16016 November 2023 BWXT Nuclear Operations Group, Inc - Lynchburg'S (BWXT NOG-L) - 30 Day Written Report of Event Notification EN-56768 ML23292A1252023-10-25025 October 2023 BWXT Nuclear Operations Group, Inc. - Integrated Inspection Report 07000027/2023003 ML23269A0242023-09-26026 September 2023 BWXT Nuclear Operations Group, Inc. - Material Control and Accounting Program Inspection Report 07000027/2023402 (Cover Letter) ML23253A0012023-09-15015 September 2023 BWXT NOG-L - Physical Security Core Inspection Report 07000027/2023405 - Cover ML23256A0092023-09-14014 September 2023 BWXT Nuclear Operations Group, Inc. Lynchburg Inspection Schedule for Calendar Year 2024 ML23257A2052023-09-0606 September 2023 Bwx Technologies, Inc. Submittal of Revision 1 to Chapter 1, General Information and Chapter 2, Organization & Administration, of License SNM-42 License Application - Redacted Cover Letter ML23248A3072023-09-0505 September 2023 Lynchburg Technology Center - Physical Security Core Inspection Report 07000027/2023406 ML23243A8582023-09-0101 September 2023 License Amendment 46 Approval of Physical Protection Plan, Revision 27 (Enterprise Project Identifier L-2023-SPR-0000) ML23241A0432023-08-24024 August 2023 Bwx Technologies, Inc., Semi-Annual Effluent Monitoring Report for First Half of 2023 ML23209A8272023-08-24024 August 2023 BWXT Nuclear Operations Group, Inc. - Lynchburg - Notice of Violation and Proposed Imposition of Civil Penalty - $87,500; NRC Inspection Report No. 07000027/2023007 ML23171A9282023-06-12012 June 2023 BWXT Nuclear Operations Group, Inc., Submittal of Emergency Plan, Revision 36 ML23171A9302023-06-12012 June 2023 BWXT Nuclear Operations Group, Inc., Submittal of Mt. Athos Site Emergency Plan, Revision 36 ML23115A0202023-05-0505 May 2023 BWXT Nuclear Operations Group, Inc., - Lynchburg - NRC Inspection Report 07000027/2023006 and Apparent Violations ML23116A0862023-04-27027 April 2023 BWXT Nuclear Operations Group, Inc. Integrated Inspection Report 07000027/2023001 ML23108A3262023-04-25025 April 2023 Cover Letter - BWXT Amendment 45 ML23100A0532023-04-0606 April 2023 BWXT Nuclear Operations Group - Lynchburg - Physical Security Core Inspection Report 07000027 2023403 Cover Letter ML23212A9182023-04-0404 April 2023 BWXT EN 56336 60 Day Report_Redacted ML23096A2252023-04-0404 April 2023 BWXT Nuclear Operations Group, Inc., Submittal of 60-Day Written Report for Event Notification Number EN-56336 ML23089A3842023-03-31031 March 2023 BWXT Nuclear Operations Group, Inc - Material Control and Accounting Program Inspection Report 07000027/2023401 ML23060A1122023-03-0606 March 2023 BWXT Nuclear Operations Group, Inc. - Licensee Performance Review (Nuclear Regulatory Commission Inspection Report 07000027/2023005) ML23059A2802023-02-23023 February 2023 BWXT Nuclear Operations Group, Inc. Submittal of Lynchburg Facility Semi-Annual Effluent Report for 2022 ML23046A0872023-02-0909 February 2023 BWXT Nuclear Operations Group- Lynchburg, Inc., Fatigue Management Program Annual Data Report ML23025A0912023-01-30030 January 2023 BWXT Nuclear Operations Group, Inc. Integrated Inspection Report 07000027/2022004 ML22341A2132022-12-15015 December 2022 Letter - BWXT Amendment 44 ML22340A5982022-11-30030 November 2022 11-30-2022 Letter from BWXT NOG-L: Request to Amend License SNM-42 in Accordance with the Revised Fundamental Nuclear Material Control Plan (FNMCP) ML22318A2632022-11-14014 November 2022 BWXT-NOG L Physical Security Core Inspection Report 07000027/2022405 (Cover Letter) ML22297A1342022-10-27027 October 2022 BWXT Nuclear Operations Group, Inc. - Integrated Inspection Report 07000027/2022003 ML22297A2082022-10-25025 October 2022 BWXT Nuclear Operations Group - Lynchburg Material Control and Accounting Program Inspection Report 07000027 2022403 Cover Letter ML23075A1782022-10-0505 October 2022 22-061 BWXT Information to Be Withheld from the Pec, Submitted Under 10 CFR 2..390(b)(1) Letter Unsecured for ADAMS Redacted (Dated - 10-5-2022) ML22263A0442022-09-15015 September 2022 BWXT Nuclear Operations Group, Inc., Emergency Plan Revision 35 2024-09-10
[Table view] |
Text
October 2, 2018 Mr. B. Joel Burch, Vice President and General Manager BWXT Nuclear Operations Group, Inc.
P.O. Box 785 Lynchburg, VA 24505-0785
SUBJECT:
LETTER OF APPRECIATION FOR THE TOUR OF THE RESEARCH TEST REACTOR FUEL FABRICATION FACILITY PROVIDED TO THE U.S. NUCLEAR REGULATORY COMMISSION ON AUGUST 21, 2018 (EPID NO. L-2017-PMP-0014)
Dear Mr. Burch:
On August 21, 2018, 13 members of the U.S. Nuclear Regulatory Commission (NRC) Division of Licensing Projects, Research and Test Reactors Oversight Branch, and Research and Test Reactors Licensing Branch staff, participated in a tour of the BWXT Research Test Reactor Fuel Fabrication Facility in Lynchburg, Virginia. The purpose of the tour was to gain insights into both the existing research reactor plate fuel production process, as well as the fuel development work being conducted in conjunction with the U.S. Department of Energy, Office of Material Management and Minimization, High Performance Research Reactor Conversion project.
The NRC staff gained important technical insights on this tour, and will be better informed with respect to future licensing actions involving research reactor fuel. Furthermore, the NRC staff recognized the level of effort expended by BWXT to provide this tour, and wish to express its appreciation to your staff: Mr. Van Mauney, Mr. David Miller, Mr. Scott Niedzialek, Mr. Chris Terry, Mr. Stephen Subosits, and Ms. Sandra Rice, and other BWXT staff, who provided both technical tour information as well as coordinated itinerary, schedule, and site access support.
If you have any questions, please contact Mr. Geoffrey Wertz at 301-415-0893, or by electronic mail to Geoffrey.Wertz@nrc.gov.
Sincerely,
/RA/
Mary Jane Ross-Lee, Deputy Division Director Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 70-27 License No. SNM-42
ML18268A344 *concurrence via email OFFICE NRR/DLP/PRLB/PM* NRR/DLP/PRLB/LA* NRR/DLP/PRLB/BC NRR/DLP/DD NAME GWertz NParker AAdams MJRoss-Lee DATE 9/26/2018 9/26/2018 10/1/2018 10/2/2018